3,4-methylenedioxyamphetamine has been researched along with ketanserin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 6 (54.55) | 18.2507 |
| 2000's | 1 (9.09) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glennon, RA | 1 |
| Brodkin, J; Nash, JF | 1 |
| Gudelsky, GA; Meltzer, HY; Nash, JF | 1 |
| Arora, RC; Meltzer, HY; Nash, JF; Schreiber, MA | 1 |
| Azmitia, EC; Murphy, RB; Whitaker-Azmitia, PM | 1 |
| Appel, NM; De Souza, EB; Glennon, RA; Leonhardt, S; Teitler, M | 1 |
| Nash, JF | 1 |
| Barrett, JE; Hoffmann, SM; Nader, MA | 1 |
| Schmidt, CJ; Taylor, VL | 1 |
| Baker, GB; Fletcher, PJ; Korth, KM; Robinson, SR | 1 |
| Camarasa, J; Escubedo, E; López-Arnau, R; Martínez-Clemente, J; Pubill, D | 1 |
11 other study(ies) available for 3,4-methylenedioxyamphetamine and ketanserin
| Article | Year |
|---|---|
The 2014 Philip S. Portoghese Medicinal Chemistry Lectureship: The "Phenylalkylaminome" with a Focus on Selected Drugs of Abuse.
Topics: Animals; Central Nervous System Stimulants; Chemistry, Pharmaceutical; Dopamine; Drug Discovery; Hallucinogens; Humans; Illicit Drugs; Norepinephrine; Phenethylamines; Psychotropic Drugs; Receptors, Serotonin; Serotonin | 2017 |
Microdialysis studies on 3,4-methylenedioxymethamphetamine-induced dopamine release: effect of dopamine uptake inhibitors.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Fluoxetine; Ketanserin; Male; Mazindol; N-Methyl-3,4-methylenedioxyamphetamine; Neurotransmitter Uptake Inhibitors; Piperazines; Rats; Rats, Inbred Strains; Serotonin | 1991 |
Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Corpus Striatum; Dihydroxyphenylalanine; Dose-Response Relationship, Drug; Hydroxyindoleacetic Acid; Ketanserin; Male; N-Methyl-3,4-methylenedioxyamphetamine; Nucleus Accumbens; Rats; Rats, Inbred Strains; Septal Nuclei; Serotonin; Serotonin Antagonists | 1990 |
Effect of 3,4-methylenedioxymethamphetamine on [3H]paroxetine binding in the frontal cortex and blood platelets of rats.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Blood Platelets; Frontal Lobe; Hydroxyindoleacetic Acid; Ketanserin; Kinetics; Male; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Piperidines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Time Factors; Tritium | 1991 |
MDMA (ecstasy) effects on cultured serotonergic neurons: evidence for Ca2(+)-dependent toxicity linked to release.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Calcium; Cells, Cultured; Embryo, Mammalian; Fluoxetine; Ketanserin; N-Methyl-3,4-methylenedioxyamphetamine; Raphe Nuclei; Rats; Serotonin | 1990 |
Receptor pharmacology of MDMA and related hallucinogens.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Binding, Competitive; Brain; Cell Membrane; Cerebral Cortex; Designer Drugs; DOM 2,5-Dimethoxy-4-Methylamphetamine; Hallucinogens; Ketanserin; Kinetics; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1990 |
Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dialysis; Dopamine; Ketanserin; Male; N-Methyl-3,4-methylenedioxyamphetamine; Rats; Rats, Inbred Strains; Receptors, Serotonin | 1990 |
Behavioral effects of (+-) 3,4-methylenedioxyamphetamine (MDA) and (+-) 3,4-methylenedioxymethamphetamine (MDMA) in the pigeon: interactions with noradrenergic and serotonergic systems.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Behavior, Animal; Columbidae; Conditioning, Operant; Dose-Response Relationship, Drug; Female; Ketanserin; Male; Metergoline; N-Methyl-3,4-methylenedioxyamphetamine; Norepinephrine; Prazosin; Reinforcement Schedule; Serotonin; Sympathetic Nervous System | 1989 |
Depression of rat brain tryptophan hydroxylase activity following the acute administration of methylenedioxymethamphetamine.
Topics: 3,4-Methylenedioxyamphetamine; Amphetamines; Animals; Cerebral Cortex; Citalopram; Dose-Response Relationship, Drug; Fluoxetine; Ketanserin; Kinetics; Male; Methiothepin; N-Methyl-3,4-methylenedioxyamphetamine; Piperonyl Butoxide; Propylamines; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tryptophan Hydroxylase | 1987 |
Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Conditioning, Operant; Dose-Response Relationship, Drug; Ethylamines; Indoles; Ketanserin; Male; Motor Activity; Oxadiazoles; Piperazines; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reinforcement, Psychology; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists; Time Factors | 2002 |
Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Brain; Carrier Proteins; Central Nervous System Stimulants; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Haloperidol; Ketanserin; Male; Methamphetamine; Mice; Molecular Structure; Motor Activity; Norepinephrine; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Antagonists; Synaptosomes | 2012 |